Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1978 Jun 24;1(6128):1664–1667. doi: 10.1136/bmj.1.6128.1664

Factors influencing postoperative morbidity and mortality in patients treated with bleomycin.

P L Goldiner, G C Carlon, E Cvitkovic, O Schweizer, W S Howland
PMCID: PMC1605498  PMID: 77697

Abstract

Patients treated with bleomycin are at risk of developing the acute adult respiratory distress syndrome post-operatively. In a prospective study of 12 patients who had received bleomycin preoperatively and were undergoing removal of retroperitoneal lymph nodes or pulmonary metastases several preventive factors were established. These were the use of low concentrations of inspired oxygen during operation and in the immediate postoperative period, careful monitoring of fluid replacement, and restriction of crystalloids in favour of colloids.

Full text

PDF
1664

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blum R. H., Carter S. K., Agre K. A clinical review of bleomycin--a new antineoplastic agent. Cancer. 1973 Apr;31(4):903–914. doi: 10.1002/1097-0142(197304)31:4<903::aid-cncr2820310422>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  2. Daskal Y., Gyorkey F., Gyorkey P., Busch H. Ultrastructural study of pulmonary bleomycin toxicity. Cancer Res. 1976 Apr;36(4):1267–1272. [PubMed] [Google Scholar]
  3. Einhorn L., Krause M., Hornback N., Furnas B. Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer. Cancer. 1976 May;37(5):2414–2416. doi: 10.1002/1097-0142(197605)37:5<2414::aid-cncr2820370533>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  4. Haas C. D., Coltman C. A., Jr, Gottlieb J. A., Haut A., Luce J. K., Talley R. W., Samal B., Wilson H. E., Hoogstraten B. Phase II evaluation of bleomycin. A Southwest oncology Group study. Cancer. 1976 Jul;38(1):8–12. doi: 10.1002/1097-0142(197607)38:1<8::aid-cncr2820380103>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  5. Iacovino J. R., Leitner J., Abbas A. K., Lokich J. J., Snider G. L. Fatal pulmonary reaction from low doses of bleomycin. An idiosyncratic tissue response. JAMA. 1976 Mar 22;235(12):1253–1255. doi: 10.1001/jama.235.12.1253. [DOI] [PubMed] [Google Scholar]
  6. O'Neill T. J., Kardinal C. G., Tierney L. M. Reversible interstitial pneumonitis associated with low dose bleomycin. Chest. 1975 Aug;68(2):265–267. doi: 10.1378/chest.68.2.265. [DOI] [PubMed] [Google Scholar]
  7. Perez-Guerra F., Harkleroad L. E., Walsh R. E., Costanzi J. J. Acute bleomycin lung. Am Rev Respir Dis. 1972 Dec;106(6):909–913. doi: 10.1164/arrd.1972.106.6.909. [DOI] [PubMed] [Google Scholar]
  8. Samuels M. L., Johnson D. E., Holoye P. Y., Lanzotti V. J. Large-dose bleomycin therapy and pulmonary toxicity. A possible role of prior radiotherapy. JAMA. 1976 Mar 15;235(11):1117–1120. [PubMed] [Google Scholar]
  9. Skillman J. J. The role of albumin and oncotically active fluids in shock. Crit Care Med. 1976 Mar-Apr;4(2):55–61. doi: 10.1097/00003246-197603000-00003. [DOI] [PubMed] [Google Scholar]
  10. Sonntag R. W., Brunner K. W., Batz K., Ryssel H. J. Treatment of metastatic testicular carcinoma with bleomycin (NSC-125066) used alone or in combination with CCNU (NSC-79037). Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):429–431. [PubMed] [Google Scholar]
  11. Winter P. M., Smith G. The toxicity of oxygen. Anesthesiology. 1972 Aug;37(2):210–241. doi: 10.1097/00000542-197208000-00010. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES